Gwynn, A.
Mbewana, S.
Lubisi, B. A.
Tshabalala, H. M.
Rybicki, E. P.
Meyers, A. E. http://orcid.org/0000-0002-2116-7913
Funding for this research was provided by:
Technology and Innovation Agency (TAHIC13-00023-CC)
University of Cape Town
Article History
Received: 15 November 2022
Accepted: 29 April 2023
First Online: 13 June 2023
Declarations
:
: A Gwynn declares no financial interests. AE Meyers is a shareholder in a molecular biopharming firm (Cape Bio Pharms Pty Ltd, Cape Town, South Africa). There are no other competing interests.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the University of Cape Town Animal Ethics Committee (AEC020-023).